Shielding likely reduced COVID exposure for pregnant people early in pandemic

Those already pregnant at the beginning of the pandemic had a 50% lower exposure to SARS-CoV-2 compared with those who became pregnant after the pandemic began and the general population, Weill Cornell researchers and colleagues found.

Experimental vaccines offer long-term protection against severe COVID

Researchers from Weill Cornell Medicine and colleagues found that two-dose vaccines still provide protection against lung disease in rhesus macaques a year after they had been vaccinated as infants.

To prevent the next pandemic, restore wildlife habitats

Preserving and restoring natural habitats could prevent pathogens that originate in wildlife from spilling over into domesticated animals and humans, according to two new companion studies.

Theory explains recovery delays in COVID and cardiac patients

The long delays some COVID patients experience in regaining consciousness after ventilation may protect the brain from oxygen deprivation, new research shows.  

Grant to fund global study of COVID-19 surveillance

With the six-month, $1 million grant, Weill Cornell Medicine researchers will assess how countries have been monitoring and reporting COVID-19 infections and outcomes.

Library events highlight open access research

Library celebrates Open Access Week with talks, panels

Around Cornell

Protein IDs, drug candidates, show promise for COVID science

A highly innovative method using the latest technology opens myriad new avenues for research, for understanding the biology behind COVID-19, and for identifying new treatments that target protein binding sites.

Book: Partisanship led to disastrous response to COVID-19

The confusing response to COVID-19 in the U.S. resulted from decisions by President Donald Trump and his allies to politicize the pandemic by associating it with his own fate in office, according to a new book by a Cornell author.

Efficacy, cash and more will increase booster shot acceptance

According to new Cornell research, people are more likely to accept the COVID-19 booster the more effective it is, if there are cash incentives and if it is made by Moderna or Pfizer.